New Covid-19 drug trial available for over-50s and those with underlying health issues

By Q Radio News

Health Minister Robin Swann is urging the over-50s and anyone with an underlying health condition here to take part in a world-leading study on life-saving COVID-19 antiviral drugs.

The PANORAMIC trial, run by the University of Oxford, is open to these groups if they test positive for COVID-19.

Around 4,500 participants across the UK have already signed up to the study, but thousands more are being recruited.

Mr Swann says they can sign up to the study as soon as they receive a positive PCR or lateral flow test result.

The Minister said:

“Vaccines remain our most important defence against the effects of COVID-19, but these antivirals are vital in helping to protect the most vulnerable from serious illness and hospitalisation.

“Patients from Northern Ireland are among the thousands who have received the new drugs but at least 6,000 more participants are needed across the UK as soon as possible.

This is so that expert scientists can understand more about how to deploy these life saving treatments in the health service more widely later in the year.

“If you’re eligible, please step forward for the PANORAMIC trial and play your part in helping us to learn more about medicines which could save thousands of lives.” 

Antivirals are medicines which are swallowed as a capsule to help treat people with COVID-19 infections to reduce the risk of hospitalisations and death.

Molnupiravir, which is currently being deployed through the study, has shown to reduce this for at risk, non-hospitalised adults with mild to moderate COVID-19 by 30% - potentially saving thousands of lives once the drugs are widely available in the health service. 

Chief Medical Officer Professor Sir Michael McBride said:

“Antivirals are used after someone contracts the virus to slow it down, make symptoms less severe and complications less common.

"It is so important that those vulnerable to COVID-19 have the best possible chance of staying protected against the virus and, most importantly, staying out of hospital.

"Antivirals can help with this. If you’re eligible for PANORAMIC please give serious consideration to taking part. This will help us decide how to use COVID-19 antiviral drugs for many years to come.”